Production (Stage)
Oncolytics Biotech Inc.
ONCY
$0.36
$0.02728.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -51.30% | -58.09% | -50.92% | -1.26% | -0.31% |
| Total Receivables | -17.80% | 314.91% | 89.19% | 977.75% | -2.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -42.16% | -46.70% | -55.10% | -46.51% | -20.97% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 84.48% | -- | 90.14% | 96.26% | -0.56% |
| Total Current Assets | -47.83% | -54.62% | -49.39% | -4.38% | -2.65% |
|
|
|||||
| Total Current Assets | -47.83% | -54.62% | -49.39% | -4.38% | -2.65% |
| Net Property, Plant & Equipment | -16.33% | 86.12% | 79.64% | 86.76% | 62.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -46.59% | -52.27% | -47.29% | -2.94% | -1.72% |
|
|
|||||
| Total Accounts Payable | -1.35% | -7.79% | 56.91% | 36.29% | 40.80% |
| Total Accrued Expenses | 37.04% | 36.57% | 48.98% | 109.94% | 68.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 52.65% | 91.16% | 31.59% | 63.75% | -5.37% |
| Total Finance Division Other Current Liabilities | 58.99% | 179.17% | -90.74% | 696.45% | 553.24% |
| Total Other Current Liabilities | 58.99% | 179.17% | -90.74% | 696.45% | 553.24% |
| Total Current Liabilities | 32.44% | 44.86% | -23.42% | 123.98% | 66.05% |
|
|
|||||
| Total Current Liabilities | 32.44% | 44.86% | -23.42% | 123.98% | 66.05% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -29.44% | 149.09% | 152.01% | 149.14% | 150.57% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -5.79% | -8.22% | 0.13% | -3.25% | -0.08% |
| Total Liabilities | 5.62% | 15.81% | -10.81% | 36.85% | 22.91% |
|
|
|||||
| Common Stock & APIC | -2.87% | -6.33% | 1.77% | 1.85% | 5.56% |
| Retained Earnings | -0.76% | 1.69% | -6.39% | -3.03% | -6.55% |
| Treasury Stock & Other | 34.70% | 62.15% | -0.17% | 26.08% | 1.58% |
| Total Common Equity | -73.36% | -80.08% | -68.75% | -20.34% | -10.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -73.36% | -80.08% | -68.75% | -20.34% | -10.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -73.36% | -80.08% | -68.75% | -20.34% | -10.88% |
|
|
|||||